-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Bill Aims to Improve Childhood Cancer Research
The STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
Healing Through Art
The Breast Cancer Art Project encourages breast cancer patients and survivors to produce—and share—art about their cancer experiences.
by Ashley P. Taylor
-
The Many Faces of Patient Advocacy
Advocates shared their stories and projects at the AACR Annual Meeting.
by Kate Yandell
-
A Response to Roadblocks
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
-
Focusing on the Fundamentals
National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
-
Supporting Survivors
Panel of experts discuss survivorship challenges and potential areas for study.
by Marci A. Landsmann
-
Cancer Researchers Offer Reasons for Optimism
Cancer researchers and patient advocates spoke about progress against cancer at a public education forum sponsored by the American Association for Cancer Research.
by Kevin McLaughlin
-
The Evolving Role of Patient Advocacy
AACR’s Scientist↔Survivor Program marks a milestone as patient advocates continue to shape research and policy.
by Marci A. Landsmann
-
An Advocate’s Guide to Attending Scientific Meetings
Two graduates of the AACR Scientist↔Survivor Program share tips for getting the most out of large scientific conferences.
by Bob Riter and Carole Baas
Cancer Talk
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live Longer
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.